Alps Medical Breakthroughs ETF (NY: SBIO )
51.60 USD +1.33 (+2.65%) Official Closing Price Updated: 7:59 PM EST, Mar 5, 2021 Add to My Watchlist
All news about Alps Medical Breakthroughs ETF
Troubling Technical News for Biotech ETFs
June 22, 2016
Already under significant pressure, the iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotech exchange traded funds face a predictable result...
Biotechnology-related exchange traded funds are stuck in a malaise, with the underlying biotech sector declining for the ninth consecutive session, its longest selloff in a twenty years. Since June 6,...
Revitalizing the merger and acquisition outlook for biotech sector exchange traded funds, Pfizer (NYSE: PFE) announced it will buy biopharma company Anacor Pharmaceuticals (NasdaqGS: ANAC). Pfizer paid...
ETF TMI: 2 Themed ETFs Launch; Energy, MLPs Active
May 10, 2016
Got a case of TMI (Too Much Information)? ETF Trends takes a condensed look at latest happenings… Global X Launches Longevity and Health & Wellness ETFs on Nasdaq Global X Funds is on a roll, launching...
Hit The Lab With These 17 Biotech ETFs
May 02, 2016
The time to buy, regardless of sector, is usually when a particular group falls out of favor, not when it has been bid higher by scores of investors. Some investors view that as the case with the...
While the health industry has underperformed so far this year, health care stocks and sector-related exchange traded funds can gain momentum on increased merger and acquisition activity. About $144...
4 Sector ETFs at a Bargain
April 06, 2016
A string of woes hurt the U.S. market momentum in the first quarter of 2016 with the S&P 500 barely adding gains thanks to global growth issues and persistent worries in the oil patch.
Pfizer (NasdaqGS: PFE) called off the deal with Allergan (NasdaqGS: AGN) on Wednesday, but there was a silver lining. Exchange traded funds that track the biotechnology sector surged as traders...
If you made investments in exchange-traded funds focused on gold and bet against those pegged to biotechnology, you would have made a pretty penny in the first quarter of 2016.
Biotech ETFs Look Green on Earnings Concerns
January 11, 2016
We are heading into the earnings season, and investors are growing concerned over the outlook for biotechnology stocks and sector-related exchange traded funds as bellwether Celgene Corp. (NasdaqGS:...
Top Sectors of 2015 and Their Leading ETFs
January 03, 2016
Technology was the second best performing sector of 2015. In an increasingly digitalized world, demand for novel and advanced technologies such as cloud computing, big data, smartphones, and high-speed...
Best & Worst ETFs Of 2015
December 31, 2015
Keeping a year-end tradition alive, let’s look back at the best and the worst of 2015. We did a quick recap of the ETFs that rocked and flopped this year with the ups and downs in the global economy.
5 Top Performing Stocks of the Top ETF of 2015
December 28, 2015
We have highlighted five best performing stocks in the ETF with their respective positions in the fund’s basket: ANAC, DYAX, RARE, IMGN and SBIO.
Tags Stocks / Equities
Five ETF Outperformers with 20% Plus Gains Year to Date
December 09, 2015
A dramatic slide in oil prices and a stronger dollar continued to hurt the performances of the benchmarks throughout the year. Though many ETFs followed the overall trend of the market movement, some...
5 ETF Winners from Q3 Earnings Season
November 10, 2015
The Q3 2015 earnings picture appears weak especially with companies struggling to beat even low top-line estimates and declining fourth-quarter estimates.
Top ETF Stories to Watch for in November
November 04, 2015
The third quarter was shockingly downbeat for the broader U.S. market and the global indices with the China-led tumult culminating into a bloodbath in August and September. Needless to say, investors...
Biotech ETFs Start Week With A Surge
November 02, 2015
Another acquisition deal in the biotechnology space for a rare disease specialist is fueling a jump in biotech stocks and sector-related exchange traded funds as traders hope further consolidation will...
ETF Pick of the Month: Buy the Dip in This Sector Leader
October 30, 2015
ETFdb.com is recommending a new long position for the month ahead, for those who wish to establish exposure to a sector leader after a steep correction in this corner of the equity market.
Biotech ETFs, Examined
October 09, 2015
Comparing the various Biotech ETFs in terms of holdings, diversification, fees, performance. Also chart analysis of IBB.
Biotech ETFs, Examined
October 09, 2015
Let's take a look at the biggest Biotech ETFs, as this was one of the market's top sectors for several years and has recently undergone a pretty strong correction.
Two Big Factors Hurting Biotech ETFs
October 06, 2015
Exorbitant drug price concerns and a new Trans-Pacific Partnership deal sent biotech stocks and sector exchange traded funds reeling Tuesday. Biotech sector stocks were among the worst performing areas...
Ill At Ease With Biotech? Prescribing #1 Healthcare ETFs
September 29, 2015
The recent carnage in biotech investing seems more vicious than anticipated. This hot corner of the broad U.S. healthcare market has seen many a correction before, but none seemed as rigorous as it...
Clinton Delivers Poison Pill To Biotech ETFs
September 21, 2015
If you’re on team Hillary Clinton in the upcoming presidential election, you might want to trim down exposure to biotechnology stocks and sector-related exchange traded funds. “Price gouging like this...
Which ETFs Liked the Fed News
September 17, 2015
The equities market and stock exchange traded funds jumped after the Federal Reserve announced it will be standing pat on record low U.S. interest rates for now in light of the weak economy, stubbornly...
Thinking Out of the Box: 5 Unique Plays on Health Care
August 10, 2015
One of the best things about exchange-traded funds (ETFs) is that they allow investors to take calculated sector bets, both long- and short-term, on the industries that have the most promising...
Hit & Flop ETFs Of July
August 01, 2015
The month of July was chockablock with economic events,some crashing the global market and some showing smart gains. Investors might want to check out the top and worst performing ETFs to see which...
3 Unique ETFs Beating The Market
July 31, 2015
With the domestic economy recovering slowly but steadily and interest rates expected to remain low in near future, the overall backdrop for US stocks remains positive.
ETF Chart of the Day: Biotechnology Breakthroughs
July 31, 2015
Yesterday we spoke about the U.S. Biotech Equity sector generally, specifically in terms of impressive net inflows in 2015 as well as in the short term in IBB (iShares NASDAQ Biotechnology, Expense...
ETF Chart of the Day: Hot Biotechnology Sector
July 30, 2015
This week we have seen decent sized inflows in the largest Biotech Equity based ETP in the U.S. listed landscape, IBB (iShares NASDAQ Biotechnology, Expense Ratio 0.48%), to the tune of about $400...